Related Experiment Video
Updated: Aug 14, 2026

Activation of Apoptosis by Cytoplasmic Microinjection of Cytochrome c
Published on: June 29, 2011
c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines
E A Harrington1, M R Bennett, A Fanidi
1Biochemistry of the Cell Nucleus Laboratory, Imperial Cancer Research Fund Laboratories, London, UK.
Abstract:
We have investigated the mechanism by which deregulated expression of c-Myc induces death by apoptosis in serum-deprived fibroblasts. We demonstrate that Myc-induced apoptosis in low serum is inhibited by a restricted group of cytokines, principally the insulin-like growth factors and PDGF. Cytokine-mediated protection from apoptosis is not linked to the cytokines' abilities to promote growth. Protection from apoptosis is evident in the post-commitment (mitogen-independent) S/G2/M phases of the cell cycle and also in cells that are profoundly blocked in cell cycle progression by drugs. Moreover, IGF-I inhibition of apoptosis occurs in the absence of protein synthesis, and so does not require immediate early gene expression. We conclude that c-Myc-induced apoptosis does not result from a conflict of growth signals but appears to be a normal physiological aspect of c-Myc function whose execution is regulated by the availability of survival factors. We discuss the possible implications of these findings for models of mammalian cell growth in vivo.
Insights
Dereguled c-Myc expression triggers apoptosis in fibroblasts, but survival factors like insulin-like growth factors can prevent this cell death. This regulation is independent of cell growth signals.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Dereguled expression of the c-Myc oncogene is implicated in various cancers.
- Understanding the mechanisms of c-Myc-induced apoptosis is crucial for cancer therapy development.
Purpose of the Study:
- To investigate how deregulated c-Myc expression induces apoptosis in serum-deprived fibroblasts.
- To identify factors that inhibit Myc-induced apoptosis and elucidate the underlying mechanisms.
Main Methods:
- Utilized serum-deprived fibroblast cell cultures.
- Investigated the effects of specific cytokines, including insulin-like growth factors (IGFs) and platelet-derived growth factor (PDGF).
- Assessed apoptosis inhibition across different cell cycle phases and in drug-induced cell cycle arrest.
Main Results:
- Cytokines, particularly IGFs and PDGF, inhibit c-Myc-induced apoptosis in low serum conditions.
- Cytokine-mediated protection is independent of their growth-promoting abilities.
- Apoptosis inhibition occurs in post-commitment cell cycle phases (S/G2/M) and in cells with drug-induced cell cycle arrest.
- Insulin-like growth factor 1 (IGF-I) inhibition of apoptosis proceeds without protein synthesis, indicating no requirement for immediate early gene expression.
Conclusions:
- c-Myc-induced apoptosis is a physiological process regulated by the availability of survival factors, not a result of conflicting growth signals.
- Survival factors play a critical role in modulating c-Myc's apoptotic function.
- These findings have implications for understanding mammalian cell growth regulation in vivo and potential therapeutic strategies targeting c-Myc-driven cancers.
More Related Videos
Related Concept Videos
Inhibition of Cdk Activity
Mitogens and the Cell Cycle
Abnormal Proliferation
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Induced Pluripotent Stem Cells
Somatic cells are...

